A multicenter randomized phase II study of full-dose gemcitabine and concurrent radiotherapy comparing gemcitabine alone for the unresectable locally advanced pancreatic adenocarcinoma.

Tatsuya Ioka,Rena Takakura,Akihiko Nakaizumi,Shinji Tanaka,Hiroyasu Iishi,Satoaki Nakamura,Kinji Nishiyama,H. Oohigashi,Osamu Ishikawa,A. Watanabe,S. Mukai

A multicenter randomized phase II study of full-dose gemcitabine and concurrent radiotherapy comparing gemcitabine alone for the unresectable locally advanced pancreatic adenocarcinoma.

2009

Tatsuya Ioka
Rena Takakura
Akihiko Nakaizumi
Shinji Tanaka
Hiroyasu Iishi
Satoaki Nakamura
Kinji Nishiyama
H. Oohigashi
Osamu Ishikawa
A. Watanabe
S. Mukai

e15512 Background: Some of locally advanced pancreatic cancers (LAPC) are considered to include a potential micro metastasis. We think that full-dose of gemcitabine (GEM) improve the outcome of LAP...

Keywords:

Physical therapy
Cancer research
Phases of clinical research
Radiation therapy
Gemcitabine
Adenocarcinoma
Oncology
Internal medicine
Medicine
Metastasis
locally advanced

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations